SCHEMBL10079529

SCHEMBL10079529

COC1C(=O)c2ccccc2C(=O)C1OC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
TP53 P04637 4/20 0.48
RAB9A P51151 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 2/20 0.48
NPC1 O15118 2/20 0.48
MAOA P21397 1/20 0.48
PTGS2 P35354 1/20 0.48
MEN1 O00255 5/20 0.48
KMT2A Q03164 5/20 0.48
POLB P06746 2/20 0.48
S100A4 P26447 1/20 0.48
ALDH1A1 P00352 3/20 0.46
CDC25B P30305 3/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CDC25A P30304 2/20 0.46
KDM4E B2RXH2 2/20 0.46
TDP1 Q9NUW8 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14939357 0.80 MAPT (0.48) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL11547901 0.75 EDNRA (0.43) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL1699526 0.75 ACHE (0.58) LMNA
SCHEMBL333528 0.74 ELANE (0.36)
SCHEMBL7317169 0.73 TP53 (0.40) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL19489752 0.72 POLB (0.54) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL677629 0.70 MEN1 (0.55) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL15245116 0.70 MEN1 (0.55) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL10079528 0.70 S100A4 (0.53) MAPTTP53RAB9ASMN1; SMN2HPGD
SCHEMBL8365427 0.70 ALDH1A1 (0.58) MAPTTP53RAB9ASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012018948-A2 NOVEL TREATMENT OF PROSTATE CARCINOMA PELLFICURE PHARMACEUTICALS, INC. (US) 2012-02-09 WO disclosed